Menarini Biotech
Tania Serlenga is a Quality Control Analyst at Menarini Biotech, a position held since July 2021, with prior experience as a Quality Control Analyst Consultant at Aenova through Amaris Consulting in May and June 2021, and as a Quality Control Microbiology Analyst at Sanofi from September 2020 to March 2021. Tania possesses expertise in cGMP and SOP, environmental monitoring, and various microbiological testing methods, including bioburden and LAL tests. An academic background includes a degree in Pharmaceutical Chemistry and Technology from Università degli Studi di Bari, along with a global thesis conducted at CiQUS focused on pharmaceutical chemistry. Additional skills encompass multicomponent reactions, chromatography techniques, and laboratory analysis methods.
This person is not in the org chart
Menarini Biotech
4 followers
Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins. Our Quality System complies with AIFA/EU GMP requirements.